有大量的研究表明它们并不是很好的标志物，因为甲胎蛋白和其他两个标志物也仅仅在晚期癌症表达更加常见。
There is a good deal of data to suggest that they are not very good markers because alpha fetoprotein and these other two markers are also more common and more commonly expressed in advanced cancers.
第二点是关于应用这些标志物的资料证实，活组织检查表明不是癌症的某些东西，多数情况下是早期疾病的问题。
The second point is that data on the use of these markers to prove that something you biopsy is not cancer is mainly a problem with early stage disease.
虽然GPC1作为胰腺癌诊断的生物标志物仍需要在更大的患者群进行验证，但这一发现展示了外泌体诊断癌症的强大力量。
Although GPC1 as a biomarker of pancreatic cancer need to be validated in larger patient cohorts, this finding exemplifies the power of utilizing exosomes for cancer diagnose.
虽然外泌体作为生物标志物用于诊断或预后在转化应用上推进很快，但基于外泌体的癌症诊断和治疗两方面都有很好的前景。
Although exosome biomarkers for diagnosis or prognosis seem to be on the fast track for translational application, both cancer diagnosis and therapy based by exosomes have bright perspectives.
背景：许多癌症中已发现DNA甲基化的存在，并以此作为生物标志物用于诊断和分型了。
Background: DNA methylation biomarkers capable of diagnosis and subtyping have been found for many cancers.
我相信，该技术将成为肿瘤免疫研究组织生物标志物研究的标准和形式设计未来的癌症治疗的基础。
I believe the Vectra technology will become the standard for tissue biomarker studies in immuno-oncology research and form the basis for tailoring cancer therapies of the future.
我相信，该技术将成为肿瘤免疫研究组织生物标志物研究的标准和形式设计未来的癌症治疗的基础。
I believe the Vectra technology will become the standard for tissue biomarker studies in immuno-oncology research and form the basis for tailoring cancer therapies of the future.
应用推荐